Hwang, Sung Ha
Kim, Haram
Lee, Dae Yeong
Nam, Dong Heun
Article History
Received: 10 April 2023
Accepted: 19 May 2023
First Online: 26 May 2023
Declarations
:
: This study was approved by the Institutional Review Board of Gachon university (IRB number: GCIRB2022-261). The study conformed to the tenets of the Declaration of Helsinki. The need for written informed consent to participate was waived by the Institutional Review Committee of Gachon University ethics committee due to the retrospective nature of the study. Based on the disclosure of conflicts of interest related to this study, the Conflict of Interest Review Board of Gachon university thoroughly investigated the data collection and patient selection.
: Not applicable.
: Dong Heun Nam is an executive and stockholder of Oculight, Inc., a Korean medical device company that provides solutions for ophthalmic surgery. Dae Yeong Lee is a stockholder at Oculight Inc. The other authors have no conflicts of interest to declare. Conflict of Interest Review Board of Gachon University thoroughly investigated the data collection and patient selection.